ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

NCI considers allowing some centers to opt out of site visits.

March 19, 2004

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

December 14, 2001

Senate Calls Cancer Research a Priority, Cites Research Task Force Funding Goal

October 8, 1999

In Brief: NCI Rushing To Complete Development Of Program Grants System By June 30

May 17, 1974

Minorities Increasingly Involved In Research, Training Programs

December 5, 1986

Samuels Says Industry Should Pay For Valium Carcinogenicity Tests

March 20, 1981